[Valvular heart disease associated with ergotamine]

Area of Science:

• Cardiology
• Neurology
• Pharmacology

Background:

• Ergotamine is a medication primarily used for migraine treatment.
• Common side effects include nausea, vomiting, myalgia, diarrhea, and dry mouth.
• Contraindications involve peripheral vascular disease and liver disease due to its vasospastic and metabolic properties, respectively.

Observation:

• The cardiac effects of ergotamine are less frequently documented.
• Two patients undergoing long-term ergotamine therapy presented with valvular disorders.

Findings:

• Long-term ergotamine use may be associated with the development of cardiac valvular disorders.
• This suggests a potential underrecognized adverse effect of chronic ergotamine treatment.

Implications:

• Clinicians should consider monitoring cardiac health in patients on long-term ergotamine.
• Further research is warranted to elucidate the mechanism and prevalence of ergotamine-induced valvular disease.